CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,893,300 | -12.8% | 666,661 | 0.0% | 0.56% | -17.4% |
| Q3 2022 | $4,467,000 | +110.2% | 666,661 | +32.1% | 0.68% | +102.7% |
| Q2 2022 | $2,125,000 | -9.2% | 504,661 | +267.8% | 0.34% | +53.0% |
| Q1 2017 | $2,340,000 | +106.7% | 137,212 | +24.7% | 0.22% | -1.4% |
| Q4 2016 | $1,132,000 | +12.0% | 110,000 | +10.0% | 0.22% | +20.0% |
| Q3 2016 | $1,011,000 | -10.0% | 100,000 | 0.0% | 0.18% | -22.9% |
| Q2 2016 | $1,123,000 | -17.8% | 100,000 | 0.0% | 0.24% | -16.4% |
| Q1 2016 | $1,366,000 | – | 100,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |